Tim Dyer

Last updated on 2015-03-09T10:49+0300.

About this image

sign

Quotes... Extracted quotes from

Tim Dyer said : “The decision of Janssen to advance ADX71149 into a Phase 2 clinical study is an exciting development and an important achievement for us,” External link

4-traders Tuesday, June 16, 2020 8:32:00 AM EAT

Tim Dyer said : “We continue to execute our registration program with dipraglurant for the treatment of PD-LID and look forward to treating patients once it is safe for centers to begin enrolling,” External link

4-traders Wednesday, May 20, 2020 8:51:00 AM EAT

Tim Dyer said : “We made significant progress in 2019 in advancing our pipeline of innovative in-house discovered allosteric modulators, including our priority dipraglurant levodopa-induced dyskinesia program, which is ready to start dosing patients in a pivotal registration clinical trial as soon as the Covid-19 crisis is over,” External link

4-traders Wednesday, April 8, 2020 9:21:00 AM EAT

Tim Dyer said : “Darryle has been pioneering novel approaches in neuroscience drug discovery and development for over three decades. His contribution to the neurology field is second to none and we are honored to have him join our team to help steer Addex’s scientific strategy,” External link

4-traders Tuesday, March 3, 2020 9:24:00 AM EAT

Tim Dyer said : “We are honored to ring the closing bell in celebration of our successful listing on Nasdaq last week. The listing was a long-term goal for Addex, which we believe will enable us to fulfil the promise of our pipeline of allosteric modulator druig candidates. This year is even more significant for Addex as we will soon begin pivotal studies with our lead product dipraglurant,” External link

4-traders Monday, February 3, 2020 9:46:00 AM EAT

Tim Dyer said ( about Citi ) : "Listing on the Nasdaq is an important step in the evolution of Addex as we approach the start of the first pivotal registration clinical study for dipraglurant, and I thank the team at Citi for their contributions to this important milestone," External link

finanznachrichten-en Thursday, January 30, 2020 1:11:00 PM EAT

Tim Dyer said : "We have made great progress in advancing our pipeline of allosteric modulator drug candidates and leveraging our technology platform through collaborations with patient advocacy groups, government and academic institutions," External link

romandie Tuesday, February 28, 2017 12:28:00 PM EAT

Tim Dyer commented : "The Janssen team has conducted outstanding research with mGlu2 PAMs and continue to validate the potential of ADX71149 in epilepsy," External link

romandie Monday, February 27, 2017 12:37:00 PM EAT

Tim Dyer said : "While we focus on our clinical stage pipeline, including dipraglurant for levodopa-induced dyskinesia associated with Parkinson's disease, we continue to advance our portfolio of discovery stage allosteric modulator programs with support from government, academic and patient advocacy organizations," External link

romandie Monday, February 6, 2017 9:42:00 AM EAT

Tim Dyer said : "We are honored to receive this award from MJFF, representing an important validation of both the capabilities of Addex' proprietary allosteric modulation platform and the quality of our TrkB PAM program," External link

romandie Tuesday, January 31, 2017 10:09:00 AM EAT

Tim Dyer said : "This recent publication in the European Journal of Pharmacology is a further demonstration of the quality of the science at Addex," External link

romandie Monday, January 9, 2017 9:56:00 AM EAT

Tim Dyer said : "We are delighted to welcome Roger to the Addex team, he brings a unique blend of drug development expertise, commercial experience and US public biotechnology company operations knowledge," External link

finanznachrichten-en Monday, November 28, 2016 10:11:00 AM EAT

Tim Dyer said : "We are delighted to welcome Roger to the Addex team, he brings a unique blend of drug development expertise, commercial experience and US public biotechnology company operations knowledge," External link

romandie Monday, November 28, 2016 9:17:00 AM EAT

Tim Dyer said : "We are excited to be kicking off this Phase IIa POC clinical trail with dipraglurant in focal cervical dystonia," External link

romandie Monday, October 17, 2016 8:26:00 AM EAT

Tim Dyer said : "We achieved a number of important milestones in the first half of 2016," External link

romandie Friday, September 30, 2016 8:32:00 AM EAT

Tim Dyer commented : "While we focus on advancing our clinical stage portfolio, including dipraglurant in Parkinson's disease levodopa-induced dyskinesia and dystonia, these new data are a great example of how we are adding value to our preclinical programs through collaboration with academic institutions" External link

romandie Tuesday, September 20, 2016 8:53:00 AM EAT

Tim Dyer commented : "This equity research report from US based LifeSci Capital provides a useful in depth analysis of the Addex investment case," External link

romandie Wednesday, July 20, 2016 9:52:00 AM EAT

Tim Dyer said : "The NIDA and NIAAA teams have done an outstanding job characterizing ADX71441 in addiction" External link

romandie Thursday, June 9, 2016 8:21:00 AM EAT

Tim Dyer déclaré : "Nous avons procédé à cette transaction pour augmenter notre flexibilité financière dans le cadre de l'avancement des développements cliniques des produits candidats dipraglurant et ADX71441" External link

romandie Monday, May 30, 2016 9:39:00 AM EAT

Tim Dyer explained : "We have executed this transaction to provide additional financing flexibility as we execute on our strategy to advance the clinical development of dipraglurant and ADX71441" External link

romandie Monday, May 30, 2016 8:31:00 AM EAT

Tim Dyer explained : "We have executed this transaction to provide additional financing flexibility as we execute on our strategy to advance the clinical development of dipraglurant and ADX71441" External link

4-traders Monday, May 30, 2016 8:20:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
chief executive officer33.33%EN02/28/201728/02/2017
ceo60.00%EN02/27/201727/02/2017
directeur général3.33%FR05/30/201630/05/2016
general manager3.33%EN03/06/201506/03/2015
Names Lang Count
Tim DyerEN81.82%
Tim DyerFR18.18%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, October 25, 2020

11:17:00 AM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Tim Dyer

Last updated on 2015-03-09T10:49+0300.

About this image

sign

Quotes... Extracted quotes from

Tim Dyer said : “The decision of Janssen to advance ADX71149 into a Phase 2 clinical study is an exciting development and an important achievement for us,” External link

4-traders Tuesday, June 16, 2020 8:32:00 AM EAT

Tim Dyer said : “We continue to execute our registration program with dipraglurant for the treatment of PD-LID and look forward to treating patients once it is safe for centers to begin enrolling,” External link

4-traders Wednesday, May 20, 2020 8:51:00 AM EAT

Tim Dyer said : “We made significant progress in 2019 in advancing our pipeline of innovative in-house discovered allosteric modulators, including our priority dipraglurant levodopa-induced dyskinesia program, which is ready to start dosing patients in a pivotal registration clinical trial as soon as the Covid-19 crisis is over,” External link

4-traders Wednesday, April 8, 2020 9:21:00 AM EAT

Tim Dyer said : “Darryle has been pioneering novel approaches in neuroscience drug discovery and development for over three decades. His contribution to the neurology field is second to none and we are honored to have him join our team to help steer Addex’s scientific strategy,” External link

4-traders Tuesday, March 3, 2020 9:24:00 AM EAT

Tim Dyer said : “We are honored to ring the closing bell in celebration of our successful listing on Nasdaq last week. The listing was a long-term goal for Addex, which we believe will enable us to fulfil the promise of our pipeline of allosteric modulator druig candidates. This year is even more significant for Addex as we will soon begin pivotal studies with our lead product dipraglurant,” External link

4-traders Monday, February 3, 2020 9:46:00 AM EAT

Tim Dyer said ( about Citi ) : "Listing on the Nasdaq is an important step in the evolution of Addex as we approach the start of the first pivotal registration clinical study for dipraglurant, and I thank the team at Citi for their contributions to this important milestone," External link

finanznachrichten-en Thursday, January 30, 2020 1:11:00 PM EAT

Tim Dyer said : "We have made great progress in advancing our pipeline of allosteric modulator drug candidates and leveraging our technology platform through collaborations with patient advocacy groups, government and academic institutions," External link

romandie Tuesday, February 28, 2017 12:28:00 PM EAT

Tim Dyer commented : "The Janssen team has conducted outstanding research with mGlu2 PAMs and continue to validate the potential of ADX71149 in epilepsy," External link

romandie Monday, February 27, 2017 12:37:00 PM EAT

Tim Dyer said : "While we focus on our clinical stage pipeline, including dipraglurant for levodopa-induced dyskinesia associated with Parkinson's disease, we continue to advance our portfolio of discovery stage allosteric modulator programs with support from government, academic and patient advocacy organizations," External link

romandie Monday, February 6, 2017 9:42:00 AM EAT

Tim Dyer said : "We are honored to receive this award from MJFF, representing an important validation of both the capabilities of Addex' proprietary allosteric modulation platform and the quality of our TrkB PAM program," External link

romandie Tuesday, January 31, 2017 10:09:00 AM EAT

Tim Dyer said : "This recent publication in the European Journal of Pharmacology is a further demonstration of the quality of the science at Addex," External link

romandie Monday, January 9, 2017 9:56:00 AM EAT

Tim Dyer said : "We are delighted to welcome Roger to the Addex team, he brings a unique blend of drug development expertise, commercial experience and US public biotechnology company operations knowledge," External link

finanznachrichten-en Monday, November 28, 2016 10:11:00 AM EAT

Tim Dyer said : "We are delighted to welcome Roger to the Addex team, he brings a unique blend of drug development expertise, commercial experience and US public biotechnology company operations knowledge," External link

romandie Monday, November 28, 2016 9:17:00 AM EAT

Tim Dyer said : "We are excited to be kicking off this Phase IIa POC clinical trail with dipraglurant in focal cervical dystonia," External link

romandie Monday, October 17, 2016 8:26:00 AM EAT

Tim Dyer said : "We achieved a number of important milestones in the first half of 2016," External link

romandie Friday, September 30, 2016 8:32:00 AM EAT

Tim Dyer commented : "While we focus on advancing our clinical stage portfolio, including dipraglurant in Parkinson's disease levodopa-induced dyskinesia and dystonia, these new data are a great example of how we are adding value to our preclinical programs through collaboration with academic institutions" External link

romandie Tuesday, September 20, 2016 8:53:00 AM EAT

Tim Dyer commented : "This equity research report from US based LifeSci Capital provides a useful in depth analysis of the Addex investment case," External link

romandie Wednesday, July 20, 2016 9:52:00 AM EAT

Tim Dyer said : "The NIDA and NIAAA teams have done an outstanding job characterizing ADX71441 in addiction" External link

romandie Thursday, June 9, 2016 8:21:00 AM EAT

Tim Dyer déclaré : "Nous avons procédé à cette transaction pour augmenter notre flexibilité financière dans le cadre de l'avancement des développements cliniques des produits candidats dipraglurant et ADX71441" External link

romandie Monday, May 30, 2016 9:39:00 AM EAT

Tim Dyer explained : "We have executed this transaction to provide additional financing flexibility as we execute on our strategy to advance the clinical development of dipraglurant and ADX71441" External link

romandie Monday, May 30, 2016 8:31:00 AM EAT

Tim Dyer explained : "We have executed this transaction to provide additional financing flexibility as we execute on our strategy to advance the clinical development of dipraglurant and ADX71441" External link

4-traders Monday, May 30, 2016 8:20:00 AM EAT



Key Titles and Phrases Count Lang Last Seen
chief executive officer33.33%EN02/28/201728/02/2017
ceo60.00%EN02/27/201727/02/2017
directeur général3.33%FR05/30/201630/05/2016
general manager3.33%EN03/06/201506/03/2015
Names Lang Count
Tim DyerEN81.82%
Tim DyerFR18.18%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Sunday, October 25, 2020

11:17:00 AM EAT


Quotes... Explore Relations


EMM Visual Explorer